ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

Obama Signs Law Authorizing $126 Million Over 10 Years for Pediatric Research

April 11, 2014

NCAB Okays New System For Bypass Budget; FY 1983 Request $1.096 Billion DCCP Board Approves Payback System For Resources Now Free

June 5, 1981

NCCN Publishes Anemia Guidelines

April 12, 2002

Charges Against CC Probed; Most Found Invalid

March 31, 1978

House, Senate Agree On $1.91 Billion NCI Appropriations

September 30, 1994